Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Astellas Pharma

Cell and Gene Therapy, Industry

BioMarin says gene therapy hold will endure as FDA questions cancer risk

February 18, 2022

Via: Biopharma Dive

With more and more gene therapies advancing into clinical testing, the FDA has paid close attention to signs of safety risks, issuing orders to stop testing in a number of recent cases involving developers like UniQure, Bluebird bio, Pfizer and […]